A total amount of £1.5 million was raised by Thriva, a health startup in a seed funding stage. Alex Chesterman, founder and CEO of Zoopla, Taavet Hinrikus, CEO and founder of TransferWise, as well as leading early stage venture funds Seedcamp, 500 Startups and the London Co-Investment Fund (LCIF) participated at the funding process.
Thriva is planning to use the new funding capital in order to expand their product range and will soon be able to analyse a variety of health markers from gut health to heavy metals to hormones. The new data will allow the company to improve their machine learning and start to provide more powerful insights and predictions.
Thriva is attempting to bring future closer, since with a simple finger-prick blood test that can be done at home, results within 48 hours, and a dashboard to track health changes over time, the startup helps people take control of their health, whether to monitor for health issues, or to help people reach peak levels of fitness.
As Thriva CEO, Hamish Grierson stated: “In 5 years time we’ll look back and think it’s ludicrous how little most people knew about what was really happening inside their bodies. We’re motivated by a simple view: That the world would be a better place if more people felt it was OK to know their bodies. Your blood can tell an amazing story about your health. Our mission is to ensure that understanding and tracking your biochemistry becomes as normal as counting your steps or jumping on the weighing scales”.